Certified by Founder Lodge
Quanta Therapeutics
United States - San Francisco and Malvern, PA
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novel therapeutics for conformational blockade of RAS in cancer.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2023 | Series D | $50,000,000 |
Vida Ventures, LLC
Longitude Capital
Sofinnova Investments
Surveyor Capital
Avidity Partners
AbbVie
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
